Adding bevacizumab to chemotherapy improves progression-free survival in ovarian cancer

  • Susan Mayor
  • British Journal of Hospital Medicine, July 2012, Mark Allen Group
  • DOI: 10.12968/hmed.2012.73.7.371a

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.12968/hmed.2012.73.7.371a

In partnership with: